216 related articles for article (PubMed ID: 20587151)
1. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.
Salama H; Zekri AR; Zern M; Bahnassy A; Loutfy S; Shalaby S; Vigen C; Burke W; Mostafa M; Medhat E; Alfi O; Huttinger E
Cell Transplant; 2010; 19(11):1475-86. PubMed ID: 20587151
[TBL] [Abstract][Full Text] [Related]
2. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.
Pai M; Zacharoulis D; Milicevic MN; Helmy S; Jiao LR; Levicar N; Tait P; Scott M; Marley SB; Jestice K; Glibetic M; Bansi D; Khan SA; Kyriakou D; Rountas C; Thillainayagam A; Nicholls JP; Jensen S; Apperley JF; Gordon MY; Habib NA
Am J Gastroenterol; 2008 Aug; 103(8):1952-8. PubMed ID: 18637092
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study.
Khan AA; Parveen N; Mahaboob VS; Rajendraprasad A; Ravindraprakash HR; Venkateswarlu J; Rao SG; Narusu ML; Khaja MN; Pramila R; Habeeb A; Habibullah CM
Transplant Proc; 2008 May; 40(4):1140-4. PubMed ID: 18555134
[TBL] [Abstract][Full Text] [Related]
4. Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.
Sharma M; Rao PN; Sasikala M; Kuncharam MR; Reddy C; Gokak V; Raju B; Singh JR; Nag P; Nageshwar Reddy D
World J Gastroenterol; 2015 Jun; 21(23):7264-71. PubMed ID: 26109814
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.
Gaia S; Smedile A; Omedè P; Olivero A; Sanavio F; Balzola F; Ottobrelli A; Abate ML; Marzano A; Rizzetto M; Tarella C
J Hepatol; 2006 Jul; 45(1):13-9. PubMed ID: 16635534
[TBL] [Abstract][Full Text] [Related]
6. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor.
Gordon MY; Levicar N; Pai M; Bachellier P; Dimarakis I; Al-Allaf F; M'Hamdi H; Thalji T; Welsh JP; Marley SB; Davies J; Dazzi F; Marelli-Berg F; Tait P; Playford R; Jiao L; Jensen S; Nicholls JP; Ayav A; Nohandani M; Farzaneh F; Gaken J; Dodge R; Alison M; Apperley JF; Lechler R; Habib NA
Stem Cells; 2006 Jul; 24(7):1822-30. PubMed ID: 16556705
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
8. Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
Tomblyn M; Burns LJ; Blazar B; Wagner J; Lee C; Rogers T; McGlave P; Miller JS; Weisdorf DJ
Bone Marrow Transplant; 2007 Jul; 40(2):111-8. PubMed ID: 17530003
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.
Amer ME; El-Sayed SZ; El-Kheir WA; Gabr H; Gomaa AA; El-Noomani N; Hegazy M
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):936-41. PubMed ID: 21900788
[TBL] [Abstract][Full Text] [Related]
10. [Granulocyte colony-stimulating factor-mobilized autologous bone marrow stem cells promote the liver regeneration of partial liver transplant: an experiment with rats].
Liu F; Pan XB; Chen GD; Jiang D; Cong X; Fei R; Wei L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3342-5. PubMed ID: 16409841
[TBL] [Abstract][Full Text] [Related]
11. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy.
Han Y; Yan L; Han G; Zhou X; Hong L; Yin Z; Zhang X; Wang S; Wang J; Sun A; Liu Z; Xie H; Wu K; Ding J; Fan D
Cytotherapy; 2008; 10(4):390-6. PubMed ID: 18574771
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
[TBL] [Abstract][Full Text] [Related]
13. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease.
Salama H; Zekri AR; Medhat E; Al Alim SA; Ahmed OS; Bahnassy AA; Lotfy MM; Ahmed R; Musa S
Stem Cell Res Ther; 2014 May; 5(3):70. PubMed ID: 24886681
[TBL] [Abstract][Full Text] [Related]
14. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.
Kharaziha P; Hellström PM; Noorinayer B; Farzaneh F; Aghajani K; Jafari F; Telkabadi M; Atashi A; Honardoost M; Zali MR; Soleimani M
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1199-205. PubMed ID: 19455046
[TBL] [Abstract][Full Text] [Related]
15. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
[TBL] [Abstract][Full Text] [Related]
16. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation.
Kiss JE; Rybka WB; Winkelstein A; deMagalhaes-Silverman M; Lister J; D'Andrea P; Ball ED
Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238
[TBL] [Abstract][Full Text] [Related]
17. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
[TBL] [Abstract][Full Text] [Related]
18. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
Weaver CH; Schwartzberg L; Li W; Hazelton B; West W
Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
